Stay updated on Taletrectinib ROS1+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.

Latest updates to the Taletrectinib ROS1+ NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAn updated revision entry v3.6.3 has been added to the study history, and the previous revision v3.6.2 has been removed.SummaryDifference0.1%

- Check19 days agoChange DetectedThe study record history now lists Revision: v3.6.2, replacing the older v3.6.0 entry and updating the page’s version history.SummaryDifference0.1%

- Check33 days agoChange DetectedThe history now shows that enrollment is closed for this study, and the latest version tag 'Revision: v3.6.0' has been added while the previous revision 'v3.5.5' was removed.SummaryDifference0.4%

- Check41 days agoChange DetectedRevision: v3.5.5 has been added to the history, replacing the previous v3.5.4, representing an updated version of the page’s historical record.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page history now includes a new revision entry labeled v3.5.4, updating the release notes metadata for this study record.SummaryDifference0.1%

- Check83 days agoChange DetectedThe site’s interface revision label updates from v3.5.2 to v3.5.3, reflecting a ClinicalTrials.gov platform/version release. No study-related information or record content changes are indicated by this change.SummaryDifference0.1%

Stay in the know with updates to Taletrectinib ROS1+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Taletrectinib ROS1+ NSCLC Clinical Trial page.